Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine‐induced nasal secretions
Authors:
- 1 March 1994
- journal article
- clinical trial
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 24 (3) , 288-290
Abstract
Summary: We performed a randomized, double‐blind, placebo‐controlled cross‐over study with two different concentrations of ipratropium bromide (Atrovent®) nasal spray to evaluate its onset and duration of inhibition. Twenty‐four subjects with perennial rhinitis participated in the trial. Fifteen minutes to 12 hours after administration of ipratropium bromide (42 or 168 μg/nostril) or placebo nasal spray, methacholine challenges were performed and nasal secretion weights measured. After placebo administration the effect of methacholine remained unchanged over the 12‐h‐period. Both the 42 and 168 μg/nostril doses significantly inhibited the nasal hypersecretions induced by methacholine challenge within 15 min of treatment (P < 0.05). The 168 μg dose of ipratropium bromide continued to significantly reduce secretion weights through 6 hours, but the effectiveness of the 42 μg dose disappeared within 3 h. In addition to having a longer duration, the 168 μg/nostril dose produced approximately twice the inhibitory effect of the 42 μg dose.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of the secretory response of the nasal mucosa to methacholine and histamineJournal of Applied Physiology, 1993
- Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: A study of its effect on their symptoms, quality of life, and nasal cytologyJournal of Allergy and Clinical Immunology, 1992
- Ipratropium bromide (atrovent nasal spray) reduces the nasal response to methacholineJournal of Allergy and Clinical Immunology, 1992
- Alterations of muscarinic acetylcholine receptors in the nasal mucosa of allergic patients in comparison with nonallergic individualsJournal of Allergy and Clinical Immunology, 1991
- How and why the nose runsJournal of Allergy and Clinical Immunology, 1991
- Anticholinergic Treatment of Watery RhinorrheaAmerican Journal of Rhinology, 1990
- Control of the hypersecretion of vasomotor rhinitis by topical ipratropium bromideJournal of Allergy and Clinical Immunology, 1987
- Cold Air-Induced Rhinorrhea and High-Dose IpratropiumJAMA Otolaryngology–Head & Neck Surgery, 1987
- Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.1981
- Innervation of human nasal glandsJournal of Neurocytology, 1972